ANI Pharmaceuticals Inc’s recent filing unveils that its SR. VP, GENERAL COUNSEL & SEC. Cook Meredith unloaded Company’s shares for reported $36036.0 on Oct 13 ’25. In the deal valued at $90.09 per share,400 shares were sold. As a result of this transaction, Cook Meredith now holds 75,674 shares worth roughly $7.06 million.
Then, Davis Krista sold 1,000 shares, generating $98,040 in total proceeds. Upon selling the shares at $98.04, the SVP, CHIEF HR OFFICER now owns 60,186 shares.
Before that, Cook Meredith sold 400 shares. ANI Pharmaceuticals Inc shares valued at $39,368 were divested by the SR. VP, GENERAL COUNSEL & SEC. at a price of $98.42 per share. As a result of the transaction, Cook Meredith now holds 76,074 shares, worth roughly $7.1 million.
H.C. Wainwright initiated its ANI Pharmaceuticals Inc [ANIP] rating to a Buy in a research note published on July 10, 2025; the price target was $84. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in mid March with a ‘”a Buy”‘ rating. JP Morgan began covering ANIP with “an Overweight” recommendation on March 12, 2025. Leerink Partners started covering the stock on December 11, 2024. It rated ANIP as “an Outperform”.
Price Performance Review of ANIP
On Tuesday, ANI Pharmaceuticals Inc [NASDAQ:ANIP] saw its stock jump 0.46% to $93.29. Over the last five days, the stock has lost -2.19%. ANI Pharmaceuticals Inc shares have risen nearly 57.37% since the year began. Nevertheless, the stocks have risen 68.76% over the past one year. While a 52-week high of $99.50 was reached on 09/10/25, a 52-week low of $52.50 was recorded on 01/13/25.
Levels Of Support And Resistance For ANIP Stock
The 24-hour chart illustrates a support level at 91.02, which if violated will result in even more drops to 88.75. On the upside, there is a resistance level at 94.60. A further resistance level may holdings at 95.91.
How much short interest is there in ANI Pharmaceuticals Inc?
A steep rise in short interest was recorded in ANI Pharmaceuticals Inc stocks on 2025-10-15, growing by 0.33 million shares to a total of 2.38 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 2.05 million shares. There was a rise of 13.75%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 11, 2024 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $68 price target.
